share_log

Bruker (NASDAQ:BRKR) Shareholders Have Endured a 26% Loss From Investing in the Stock Three Years Ago

Bruker (NASDAQ:BRKR) Shareholders Have Endured a 26% Loss From Investing in the Stock Three Years Ago

布魯克(納斯達克:BRKR)股東在三年前投資該股票時經歷了26%的損失。
Simply Wall St ·  12/15 08:37

Bruker Corporation (NASDAQ:BRKR) shareholders should be happy to see the share price up 13% in the last month. But that cannot eclipse the less-than-impressive returns over the last three years. After all, the share price is down 27% in the last three years, significantly under-performing the market.

布魯克公司(納斯達克:BRKR)的股東應該對過去一個月股價上漲13%感到高興。 但這並不能掩蓋過去三年的回報不盡人意。 畢竟,過去三年股價下跌27%,顯著落後於市場。

Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.

由於股東在長期內處於虧損狀態,我們來看看這段時間內的基本面,看看它們是否與回報一致。

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

用本傑明·格雷厄姆的話說:在短期內,市場像個投票機,但在長期內,它就是個稱重機。檢視市場情緒如何隨時間變化的一種方法是觀察一家公司的股價與每股收益(EPS)之間的互動。

During the unfortunate three years of share price decline, Bruker actually saw its earnings per share (EPS) improve by 4.1% per year. This is quite a puzzle, and suggests there might be something temporarily buoying the share price. Or else the company was over-hyped in the past, and so its growth has disappointed.

在這三年股價下跌的不幸期間,布魯克的每股收益(EPS)實際上每年提高了4.1%。 這真是個謎,暗示可能有些因素暫時支撐了股價。 否則,公司過去可能被炒作過頭,因此其增長讓人失望。

It's pretty reasonable to suspect the market was previously to bullish on the stock, and has since moderated expectations. But it's possible a look at other metrics will be enlightening.

合理懷疑市場以前對這隻股票過於看好,並且自此調低了預期。 但查看其他指標可能會有所啓發。

With a rather small yield of just 0.3% we doubt that the stock's share price is based on its dividend. Revenue is actually up 11% over the three years, so the share price drop doesn't seem to hinge on revenue, either. This analysis is just perfunctory, but it might be worth researching Bruker more closely, as sometimes stocks fall unfairly. This could present an opportunity.

鑑於僅僅0.3%的收益率,我們懷疑該股票的股價是否基於其分紅。 實際上,營業收入在三年內增長了11%,因此股價的下跌似乎也與營業收入無關。這項分析只是表面工作,但可能值得更仔細地研究Bruker,因爲有時股票會被不公平地拋售。這可能會帶來機會。

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

以下圖像顯示了公司的營業收入和盈利(隨時間變化)(單擊以查看準確的數字)。

big
NasdaqGS:BRKR Earnings and Revenue Growth December 15th 2024
納斯達克交易所:BRKR 盈利與營業收入增長 2024年12月15日

It's good to see that there was some significant insider buying in the last three months. That's a positive. That said, we think earnings and revenue growth trends are even more important factors to consider. This free report showing analyst forecasts should help you form a view on Bruker

很高興看到最近三個月內出現了一些顯著的內部買入。這是一個積極的跡象。話雖如此,我們認爲每股收益和營業收入的增長趨勢是更重要的考慮因素。這份顯示分析師預測的免費報告應該能幫助您對Bruker形成看法。

A Different Perspective

不同的視角

While the broader market gained around 30% in the last year, Bruker shareholders lost 21% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 3%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for Bruker (1 can't be ignored!) that you should be aware of before investing here.

雖然廣泛的市場去年上漲了約30%,但Bruker的股東損失了21%(即便包括分紅)。即便是優質股票的股價有時也會下跌,但在我們對一個業務產生興趣之前,我們希望看到其基本指標的改善。長期投資者不會太失望,因爲他們在五年間每年獲得了3%的收益。最近的拋售可能是一個機會,因此值得檢查基本數據以尋找長期增長趨勢的跡象。雖然考慮市場條件對股價的不同影響是非常重要的,但還有其他因素更爲重要。例如,我們發現了Bruker的2個警示信號(1個無法忽視!),在此之前投資前您應該有所了解。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar).

如果你喜歡與管理層一起買入股票,那麼你可能會喜歡這份免費的公司名單。(提示:它們中的大多數都在雷達下飛行)。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文中引用的市場回報反映了當前在美國交易所上市股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論